DSIJ Mindshare

Wockhardt Jumps On Promoters’ Stake Increase

The shares of troubled pharma company Wockhardt have surged by more than 15% on the news that the promoters have increased their stake in the company. As per news articles, Khorakiwala Holdings & Investments, the largest promoter group entity, has bought 211,094 equity shares representing 0.19% stake in the company. With this, the stake of this entity has gone up from 63.62% to 63.81%.

The company has been seeing many regulatory issues at its Waluj manufacturing facility due to the import alert and a warning letter on this facility due to the quality slip-ups on this facility. UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has also banned drugs from the same facility.

On its part, Wockhardt has said that it has taken care of all the quality-related issues and has also hired a few people who will look after the quality of drugs. The company is now deploying new software which will streamline quality and compliance system across all its manufacturing facilities. It is also undertaking a compliance training programme for all its staff responsible for compliance and quality control.

Wockhardt’s shares have tumbled from the high of Rs 2166 in March 2013 to Rs 344 in August 2013, but are now seeing some recovery. They are currently up by 54%, most of which could be on account of value buying. As per our sources, many institutions have exited from this counter. One has to wait until the end of the current quarter to see which institutions have sold the stock.

The question is should one buy the stock at this time as its current price is well below the fair value? While we at DSIJ have a target price of around Rs 700 and believe that the stock may well be on course to reach that target, it is equally true that  any further regulatory issues would prove to be a further massive value destroyer. The company has also said that the US FDA team that audited another plant has made a few observations. It is not clear yet how serious these are. We believe that only those investors with a decent risk appetite should buy this stock at this juncture.

DSIJ MINDSHARE

Mkt Commentary28-Mar, 2024

Expert Speak29-Mar, 2024

Mindshare29-Mar, 2024

Multibaggers28-Mar, 2024

Interviews28-Mar, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR